Show simple item record

dc.contributor.author Gokcekus, Omer en_US
dc.contributor.author Adams, Mike en_US
dc.contributor.author Grabowski, Henry en_US
dc.contributor.author Tower, Edward en_US
dc.date.accessioned 2010-03-09T15:41:21Z
dc.date.available 2010-03-09T15:41:21Z
dc.date.issued 2006 en_US
dc.identifier.uri http://hdl.handle.net/10161/2013
dc.description.abstract the major interest groups in the debate over allowing the re-importation of prescription drugs by utilizing a logit model and instrumental variables. Consistent with political support approach, the evidence suggests that Representatives are maximizing their electoral prospects: contributions from pharmaceutical manufacturers shrink the probability of voting for the bill; and Representatives are sensitive to their constituencies - employees of pharmaceutical manufacturing and senior citizens. Representatives' gender and ideology regarding free trade and subsidies are also determining factors. However, the decision was, by and large, a partisan one: party affiliation was the most important factor in passing the bill. en_US
dc.format.extent 144967 bytes
dc.format.mimetype application/pdf
dc.language.iso en_US
dc.publisher SSRN eLibrary en_US
dc.subject instrumental variables en_US
dc.subject logit model en_US
dc.subject prescription drugs en_US
dc.title How Did the 2003 Prescription Drug Re-Importation Bill Pass the House? en_US
dc.type Journal Article en_US
dc.department Economics

Files in this item

This item appears in the following Collection(s)

Show simple item record